Catalyst Wire Dossier Catalyst Wire Dossier

NU300 Hib vaccine

Haemophilus influenzae type b vaccine NU300 · Nuron Biotech Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NU300 Hib vaccine, covering 2013-09-23 to 2013-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers [Phase 2]

See pricing